Reset

Advanced Filters
11:00am - 11:40am EDT - June 15, 2020
Deborah L. Johnson, PhD, Keystone Symposia on Cellular and Molecular Biology; Rino Rappuoli, PhD, GlaxoSmithKline Vaccines; Dr. Anthony S. Fauci, MD, NIAID, National Institutes of Health

Monday
11:00am - 11:05am EDT - June 15, 2020
Deborah L. Johnson, PhD, Keystone Symposia on Cellular and Molecular Biology

Monday
11:05am - 11:15am EDT - June 15, 2020
Rino Rappuoli, PhD, GlaxoSmithKline Vaccines

Monday
11:15am - 11:40am EDT - June 15, 2020
Dr. Anthony S. Fauci, MD, NIAID, National Institutes of Health


In this Keynote Address, given on June 15, 2020 as part of the eSymposia “Vaccinology in the Age of Pandemics: Strategies Against COVID-19 & Other Global Threats,” Dr. Anthony Fauci outlines the latest vaccinology advances and approaches that have vastly accelerated the development of COVID-19 vaccines.

Dr. Fauci credits recent advances in technology for enabling this unprecedented rapid response, which in just the last few years have transformed vaccinology capabilities. These include:

  • Rapid genetic sequencing of new pathogens
  • Structure-based vaccine design and reverse vaccinology approaches
  • New and diverse vaccine platforms combined with improved adjuvants
  • Humanized animal models for vaccine testing

In addition, new preparedness strategies have accelerated vaccine development efforts. Since the early 2000s, researchers have been working preemptively on vaccines for emerging pathogens, and can now apply lesson learned from these efforts in COVID-19 vaccine design, development and testing. Meanwhile, preparation of clinical trial sites, manufacturing and other logistic considerations in the testing and deployment of a vaccine are critical to have ready prior to launch.

Ultimately, new partnerships between public and private sectors have enabled all of these pieces to come together at “warp speed” in the face of this new pandemic.


Explore more on the latest vaccinology advances and approaches from the eSymposia “Vaccinology in the Age of Pandemics: Strategies Against COVID-19 & Other Global Threats,” available on-demand through VKS:

custom image



11:40am - 12:35pm EDT - June 15, 2020
Barney S. Graham, MD, PhD, NIAID, National Institutes of Health; Neil P. King, PhD, University of Washington

Monday
11:40am - 12:00pm EDT - June 15, 2020
Barney S. Graham, MD, PhD, NIAID, National Institutes of Health
Track: Structure-Based Antigen Design

Monday
12:00pm - 12:20pm EDT - June 15, 2020
Neil P. King, PhD, University of Washington
Track: Structure-Based Antigen Design

Monday
12:20pm - 12:35pm EDT - June 15, 2020
Barney S. Graham, MD, PhD, NIAID, National Institutes of Health; Neil P. King, PhD, University of Washington
Track: Structure-Based Antigen Design

12:35pm - 01:35pm EDT - June 15, 2020
Gabriel D. Victora, PhD, Rockefeller University; Robert A. Seder, MD, NIAID, National Institutes of Health

Monday
12:35pm - 12:55pm EDT - June 15, 2020
Gabriel D. Victora, PhD, Rockefeller University
Track: Antigen Presentation and Delivery

Monday
12:55pm - 01:20pm EDT - June 15, 2020
Robert A. Seder, MD, NIAID, National Institutes of Health
Track: Antigen Presentation and Delivery

Monday
01:20pm - 01:35pm EDT - June 15, 2020
Robert A. Seder, MD, NIAID, National Institutes of Health; Gabriel D. Victora, PhD, Rockefeller University
Track: Antigen Presentation and Delivery

01:35pm - 02:30pm EDT - June 15, 2020
Ulrike Protzer, MD, Technische Universität München; Catherine J. Wu, MD, Dana-Farber Cancer Institute

Monday
01:35pm - 01:55pm EDT - June 15, 2020
Catherine J. Wu, MD, Dana-Farber Cancer Institute
Track: Therapeutic Vaccines

Monday
01:55pm - 02:15pm EDT - June 15, 2020
Ulrike Protzer, MD, Technische Universität München
Track: Therapeutic Vaccines

Monday
02:15pm - 02:30pm EDT - June 15, 2020
Catherine J. Wu, MD, Dana-Farber Cancer Institute; Ulrike Protzer, MD, Technische Universität München
Track: Therapeutic Vaccines

02:30pm - 03:30pm EDT - June 15, 2020
Antonio Lanzavecchia, MD, Institute for Research in Biomedicine; Hedda Wardemann, PhD, German Cancer Research Center

Monday
02:30pm - 02:45pm EDT - June 15, 2020
Hedda Wardemann, PhD, German Cancer Research Center
Track: Human Monoclonal Antibodies

Monday
02:45pm - 03:05pm EDT - June 15, 2020
Antonio Lanzavecchia, MD, Institute for Research in Biomedicine
Track: Human Monoclonal Antibodies

Monday
03:05pm - 03:20pm EDT - June 15, 2020
Antonio Lanzavecchia, MD, Institute for Research in Biomedicine; Hedda Wardemann, PhD, German Cancer Research Center
Track: Human Monoclonal Antibodies

11:00am - 11:50am EDT - June 16, 2020
Lynda M. Stuart, MD, PhD, Bill & Melinda Gates Foundation; Christine Shaw, PhD, Moderna; Robin Shattock, PhD, Imperial College London

Tuesday
11:05am - 11:20am EDT - June 16, 2020
Track: RNA Vaccines

Tuesday
11:20am - 11:35am EDT - June 16, 2020
Robin Shattock, PhD, Imperial College London
Track: RNA Vaccines

Tuesday
11:35am - 11:50am EDT - June 16, 2020
Christine Shaw, PhD, Moderna; Lynda M. Stuart, MD, PhD, Bill & Melinda Gates Foundation
Track: RNA Vaccines

11:50am - 12:50pm EDT - June 16, 2020
Galit Alter, PhD, MIT and Harvard University; Bali Pulendran, PhD, Stanford University School of Medicine

Tuesday
11:50am - 12:15pm EDT - June 16, 2020
Galit Alter, PhD, MIT and Harvard University
Track: Systems Biology

Tuesday
12:15pm - 12:35pm EDT - June 16, 2020
Bali Pulendran, PhD, Stanford University School of Medicine
Track: Systems Biology

Tuesday
12:35pm - 12:50pm EDT - June 16, 2020
Galit Alter, PhD, MIT and Harvard University; Bali Pulendran, PhD, Stanford University School of Medicine
Track: Systems Biology

12:50pm - 01:40pm EDT - June 16, 2020
Alessandro Sette, PhD, La Jolla Institute for Immunology; Yasmine Belkaid, PhD, NIAID, National Institutes of Health

Tuesday
12:50pm - 01:10pm EDT - June 16, 2020
Alessandro Sette, PhD, La Jolla Institute for Immunology
Track: Immune Response

Tuesday
01:10pm - 01:25pm EDT - June 16, 2020
Yasmine Belkaid, PhD, NIAID, National Institutes of Health
Track: Immune Response

Tuesday
01:25pm - 01:40pm EDT - June 16, 2020
Alessandro Sette, PhD, La Jolla Institute for Immunology; Yasmine Belkaid, PhD, NIAID, National Institutes of Health
Track: Immune Response

01:40pm - 03:15pm EDT - June 16, 2020
Rino Rappuoli, PhD, Moderator, GlaxoSmithKline Vaccines; Richard Hatchett, MD, Coalition for Epidemic Preparedness Innovations, CEPI; George Fu Gao, PhD, Institute of Microbiology, Chinese Academy of Sciences; Lynda M. Stuart, MD, PhD, Bill & Melinda Gates Foundation
Tags: ePanel

Tuesday
01:40pm - 01:45pm EDT - June 16, 2020
Rino Rappuoli, PhD, GlaxoSmithKline Vaccines
Track: Facing COVID-19 and other Emerging Infections

Tuesday
01:45pm - 01:50pm EDT - June 16, 2020
Richard Hatchett, MD, Coalition for Epidemic Preparedness Innovations, CEPI
Track: Facing COVID-19 and other Emerging Infections

Tuesday
01:50pm - 01:55pm EDT - June 16, 2020
George Fu Gao, PhD, Institute of Microbiology, Chinese Academy of Sciences
Track: Facing COVID-19 and other Emerging Infections

Tuesday
01:55pm - 02:00pm EDT - June 16, 2020
Lynda M. Stuart, MD, PhD, Bill & Melinda Gates Foundation
Track: Facing COVID-19 and other Emerging Infections

Tuesday
02:00pm - 03:00pm EDT - June 16, 2020
Rino Rappuoli, PhD, Moderator, GlaxoSmithKline Vaccines; Richard Hatchett, MD, Coalition for Epidemic Preparedness Innovations, CEPI; George Fu Gao, PhD, Institute of Microbiology, Chinese Academy of Sciences; Lynda M. Stuart, MD, PhD, Bill & Melinda Gates Foundation
Track: Facing COVID-19 and other Emerging Infections